phenelzine has been researched along with Leishmaniasis, Visceral in 1 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AT | 1 |
| Croft, SL | 1 |
| Peters, W | 1 |
| Neal, RA | 1 |
1 other study available for phenelzine and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
Topics: Animals; Carbidopa; Drug Evaluation, Preclinical; Drug Interactions; Leishmania donovani; Leishmania | 1989 |